Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using MC1R Genotype to Impact Melanoma Risk Behavior

NCT03509467 is registered in ClinicalTrials.gov with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor.

NCT NCT03509467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03509467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using MC1R Genotype to Impact Melanoma Risk Behavior
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Phase
Not applicable
Overall status
Completed
Start date
August 3, 2015
Completion date
February 19, 2021
Enrollment
2,054 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell cancer, basal cell carcinoma, melanoma (skin), skin cancer, squamous cell cancer, squamous cell carcinoma